Actinium Pharma Stock (AMEX: ATNM) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 300.000 / 360.650K |
Day Range | - - - |
52 Wk Range | 4.000 - 9.860 |
Market Cap | $195.192M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 38 |
Short Interest | 7.44% |
Days to Cover | 2.19 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Actinium Pharma (AMEX: ATNM) through any online brokerage.
Other companies in Actinium Pharma’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Adverum Biotechnologies (NASDAQ:ADVM), bluebird bio (NASDAQ:BLUE) and Atossa Therapeutics (NASDAQ:ATOS).
The latest price target for Actinium Pharma (AMEX: ATNM) was reported by HC Wainwright & Co. on Monday, April 1, 2024. The analyst firm set a price target for 50.00 expecting ATNM to fall to within 12 months (a possible NaN% downside). 12 analyst firms have reported ratings in the last year.
The stock price for Actinium Pharma (AMEX: ATNM) is $ last updated .
There are no upcoming dividends for Actinium Pharma.
Actinium Pharma’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for Actinium Pharma.
Actinium Pharma is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.